Showing 1 - 5 results of 5 for search 'Pirkko Lepola', query time: 0.02s Refine Results
  1. 1
    The route to financial sustainability of a large Public Private Partnership—the example of the clinical trial network conect4children (c4c)

    The route to financial sustainability of a large Public Private Partnership—the example of the clinical trial network conect4children (c4c) by Laetitia Paumard, Heidrun Hildebrand, Marianne Engel, Pirkko Lepola, Esther Montero, Frank Tennigkeit, Magda Rosenmöller

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Does the EU’s Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study

    Does the EU’s Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study by Elin Kimland, Ann Marie Tötterman, Siri Wang, Pirkko Lepola, Ninna Gullberg, Kirstine Moll Harboe

    Published 2020-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in Europe: insights from the conect4children (c4c) network

    Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in Europe: insights from the conect4children (c4c) network by Sabah Attar, Sabah Attar, Francisca P. Figueiras, Francisca P. Figueiras, Carla Peacock, Hazel Wohlfahrt, Birgitta C. P. Hüsken, Susan Andrews, Pirkko Lepola, Margaret Patton, Regis Hankard, Eren Halil, Fernando Pontes Soares, Lionel K. Tan, Ricardo M. Fernandes, Ricardo M. Fernandes, Mark A. Turner, Mark A. Turner

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process

    Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process

    Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: